Synopsis
Synopsis
0
JDMF
0
VMF
0
Australia
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
Annual Reports
NA
1. Lariam
2. Mefloquine
3. Mefloquine Hydrochloride
4. Mephloquine
5. Ro 21 5998 001
6. Ro-21-5998-001
7. Ro215998001
8. Wr 142,490
9. Wr 177,602
10. Wr-142,490
11. Wr-177,602
12. Wr142,490
13. Wr177,602
1. Mefloquine Hydrochloride
2. Mefloquine Hcl
3. 51773-92-3
4. Mefloquine (hydrochloride)
5. Loriam
6. Mefloquine Hydrochloride, (+)
7. 51742-86-0
8. 326vc85gv6
9. Ro 21-5998/001
10. Mefloquinehydrochloride
11. 5y9l3636o3
12. Ro-21-5998/001
13. (s)-[2,8-bis(trifluoromethyl)quinolin-4-yl]-[(2r)-piperidin-2-yl]methanol;hydrochloride
14. Dsstox_cid_27796
15. Dsstox_rid_82568
16. Dsstox_gsid_47819
17. Mls001332559
18. Nsc-157387
19. (r)-[2,8-bis(trifluoromethyl)quinolin-4-yl](2s)-piperidin-2-ylmethanol Hydrochloride
20. (s)-[2,8-bis(trifluoromethyl)quinolin-4-yl][(2r)-piperidin-2-yl]methanol Hydrochloride
21. Wr 142490 Hydrochloride
22. Nsc 157387
23. Cas-51773-92-3
24. Mefloquine Hydrochloride [usan]
25. Mefloquin Hydrochloride
26. Ncgc00161831-02
27. Smr000875233
28. Einecs 257-412-0
29. Wr-142490
30. Tcmdc-124288
31. Unii-326vc85gv6
32. Unii-5y9l3636o3
33. Gnf-pf-5559
34. Lariam (tn)
35. Mefloquine Hydrochloride [usan:usp]
36. Ro-215998001
37. Chembl1606
38. Dl-erythro-alpha-2-piperidyl-2,8-bis(trifluoromethyl)-4-quinolinemethanol Monohydrochloride
39. Schembl41094
40. Mls001332560
41. Chebi:6719
42. (+/-)-mefloquine Hcl
43. Dtxsid1047819
44. Tox21_111999
45. Hy-17437a
46. Mfcd00797519
47. S4420
48. Mefloquine Hydrochloride (jp17/usp)
49. Mefloquine Hydrochloride [jan]
50. Akos015919767
51. Tox21_111999_1
52. Ac-4686
53. Ccg-268825
54. Cs-1430
55. Gs-3621
56. Nc00622
57. (r*,s*)-(1)-alpha-2-piperidyl-2,8-bis(trifluoromethyl)quinoline-4-methanol Monohydrochloride
58. Mefloquine Hydrochloride [mart.]
59. Mefloquine Hydrochloride [vandf]
60. Mefloquine Hydrochloride [usp-rs]
61. Mefloquine Hydrochloride [who-dd]
62. Mefloquine Hydrochloride [who-ip]
63. Ncgc00161831-04
64. 4-quinolinemethanol, Alpha-(2r)-2-piperidinyl-2,8-bis(trifluoromethyl)-, Monohydrochloride, (alphas)-rel-
65. 4-quinolinemethanol, Alpha-2-piperidinyl-2,8-bis(trifluoromethyl)-, Monohydrochloride, (r*,s*)-(+-)-
66. M2313
67. Sw220098-1
68. Mefloquine Hydrochloride [ep Impurity]
69. Mefloquine Hydrochloride [orange Book]
70. D00831
71. Mefloquine Hydrochloride [ep Monograph]
72. Mefloquine Hydrochloride [usp Monograph]
73. Mefloquini Hydrochloridum [who-ip Latin]
74. Mefloquine Hydrochloride, >=98% (hplc), Powder
75. Q-201345
76. Mefloquine Hydrochloride, European Pharmacopoeia (ep) Reference Standard
77. (?s)-rel-?-(2r)-2-piperidinyl-2,3-bis(trifluoromethyl-4-quinolinemethanol Hydrochloride
78. (2,8-bis-trifluoromethylquinolin-4-yl)-piperidin-2-yl-methanol Hydrochloride(r*,s*)
79. Mefloquine Hydrochloride, Pharmaceutical Secondary Standard; Certified Reference Material
80. Mefloquine Hydrochloride, United States Pharmacopeia (usp) Reference Standard
81. Rel-(s)-(2,8-bis(trifluoromethyl)quinolin-4-yl)((r)-piperidin-2-yl)methanol Hydrochloride
82. (as)?-?rel-?a-?(2r)?-?2-?piperidinyl-?2,8-?bis(trifluoromethyl)?-?4-?quinolinemethanol Monohydrochloride
83. 4-quinolinemethanol, .alpha,-[(2r)-2-piperidinyl]-2,8-bis(trifluoromethyl)-, (.alpha.s)-, Hydrochloride (1:1)
84. 4-quinolinemethanol, .alpha.-(2r)-2-piperidinyl-2,8-bis(trifluoromethyl)-, Hydrochloride (1:1), (.alpha.s)-
85. 4-quinolinemethanol, .alpha.-(2r)-2-piperidinyl-2,8-bis(trifluoromethyl)-, Monohydrochloride, (.alpha.s)-
86. 4-quinolinemethanol, .alpha.-2-piperidinyl-2,8-bis(trifluoromethyl)-, Monohydrochloride, (r*,s*)- (+/-)-
87. 4-quinolinemethanol, A-(2r)-2-piperidinyl-2,8-bis(trifluoromethyl)-,monohydrochloride, (as)-rel-
88. Dl-erythro-.alpha.-2-piperidyl-2,8-bis(trifluoromethyl)-4-quinolinemethanol Monohydrochloride
Molecular Weight | 414.8 g/mol |
---|---|
Molecular Formula | C17H17ClF6N2O |
Hydrogen Bond Donor Count | 3 |
Hydrogen Bond Acceptor Count | 9 |
Rotatable Bond Count | 2 |
Exact Mass | 414.0933598 g/mol |
Monoisotopic Mass | 414.0933598 g/mol |
Topological Polar Surface Area | 45.2 Ų |
Heavy Atom Count | 27 |
Formal Charge | 0 |
Complexity | 483 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 2 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 2 |
1 of 2 | |
---|---|
Drug Name | Mefloquine hydrochloride |
Drug Label | Mefloquine hydrochloride is an antimalarial agent available as 250 mg tablets of mefloquine hydrochloride (equivalent to 228.0 mg of the free base) for oral administration.Mefloquine hydrochloride is a 4-quinolinemethanol derivative with the specific... |
Active Ingredient | Mefloquine hydrochloride |
Dosage Form | Tablet |
Route | Oral |
Strength | 250mg |
Market Status | Prescription |
Company | Sandoz; Roxane; Barr |
2 of 2 | |
---|---|
Drug Name | Mefloquine hydrochloride |
Drug Label | Mefloquine hydrochloride is an antimalarial agent available as 250 mg tablets of mefloquine hydrochloride (equivalent to 228.0 mg of the free base) for oral administration.Mefloquine hydrochloride is a 4-quinolinemethanol derivative with the specific... |
Active Ingredient | Mefloquine hydrochloride |
Dosage Form | Tablet |
Route | Oral |
Strength | 250mg |
Market Status | Prescription |
Company | Sandoz; Roxane; Barr |
Antimalarials
Agents used in the treatment of malaria. They are usually classified on the basis of their action against plasmodia at different stages in their life cycle in the human. (From AMA, Drug Evaluations Annual, 1992, p1585) (See all compounds classified as Antimalarials.)
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 15413
Submission : 2001-05-04
Status : Active
Type : II
NDC Package Code : 75877-0005
Start Marketing Date : 2017-11-28
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 15687
Submission : 2001-10-29
Status : Active
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 16127
Submission : 2002-09-06
Status : Active
Type : II
NDC Package Code : 17381-840
Start Marketing Date : 2010-04-15
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others
USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 7549
Submission : 1988-06-21
Status : Inactive
Type : II
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 22138
Submission : 2008-10-23
Status : Inactive
Type : II
Date of Issue : 2019-10-07
Valid Till : 2022-07-02
Written Confirmation Number : WC-0226
Address of the Firm :
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 26883
Submission : 2013-02-06
Status : Inactive
Type : II
Certificate Number : CEP 2011-099 - Rev 04
Issue Date : 2024-07-11
Type : Chemical
Substance Number : 1241
Status : Valid
NDC Package Code : 17337-0528
Start Marketing Date : 2017-03-03
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
Registrant Name : DKS Korea Co., Ltd.
Registration Date : 2022-09-28
Registration Number : 20220928-209-J-1371
Manufacturer Name : Olon SPA
Manufacturer Address : VIA LIVELLI, 1(loc. FRAZIONE MAIRANO) - 26852 CASALETTO LODIGIANO (LO), Italy
API Imports and Exports
Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
---|
Upgrade, download data, analyse, strategize, subscribe with us
Related Excipient Companies
Excipients by Applications
Global Sales Information
Market Place
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
LOOKING FOR A SUPPLIER?